The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Abeona Therapeutics Inc shares valued at $120,294 were sold by Vazzano Joseph Walter on Jun 06 ’25. At $6.76 per share, Vazzano Joseph Walter sold 17,795 shares. The insider’s holdings dropped to 491,246 shares worth approximately $3.07 million following the completion of this transaction.
Also, Seshadri Vishwas sold 50,676 shares, netting a total of over 342,570 in proceeds. Following the sale of shares at $6.76 each, the insider now holds 1,303,761 shares.
Before that, O’Malley Brendan M. had sold 10,470 shares from its account. In a trade valued at $70,777, the SVP, General Counsel traded Abeona Therapeutics Inc shares for $6.76 each. Upon closing the transaction, the insider’s holdings decreased to 10,470 shares, worth approximately $2.36 million.
Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early March. As of July 03, 2024, H.C. Wainwright has initiated its “Buy” rating for ABEO. Earlier on May 30, 2024, Stifel initiated its rating. Their recommendation was “a Buy” for ABEO stock.
Analyzing ABEO Stock Performance
During the last five days, there has been a drop of approximately -3.63%. Over the course of the year, Abeona Therapeutics Inc shares have jumped approximately 12.12%. Shares of the company reached a 52-week high of $7.32 on 04/30/25 and a 52-week low of $3.93 on 04/09/25.
Support And Resistance Levels for Abeona Therapeutics Inc (ABEO)
According to the 24-hour chart, there is a support level at 6.12, which, if violated, would cause prices to drop to 6.01. In the upper region, resistance lies at 6.33. The next price resistance is at 6.43. RSI (Relative Strength Index) is 52.47 on the 14-day chart, showing neutral technical sentiment.
